Rekombinanter NMDAR2A Antikörper
Kurzübersicht für Rekombinanter NMDAR2A Antikörper (ABIN7573111)
Target
Alle NMDAR2A (GRIN2A) Antikörper anzeigenAntikörpertyp
Reaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Expressionssystem
- Mammalian cells
-
Verwendungszweck
- Recombinant Anti-GluN2A/NR2A glutamate receptor Antibody (N327/95)
-
Aufreinigung
- Protein A or G purified from cell culture supernatant.
-
Reinheit
- >95 % by SDS-PAGE.
-
Isotyp
- IgG2a, kappa
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 mg/mL
-
Buffer
- 0.01M PBS, pH 7.4.
-
Lagerung
- -20 °C,-80 °C
-
Informationen zur Lagerung
- Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at +4°C short term (1-2 weeks). Store at -20 °C 12 months. Store at -80°C long term.
-
-
- NMDAR2A (GRIN2A) (Glutamate Receptor, Ionotropic, N-Methyl D-Aspartate 2a (GRIN2A))
-
Andere Bezeichnung
- GRIN2A
-
Hintergrund
- N-methyl D-aspartate receptor subtype 2A, NMDAR2A, Glutamate [NMDA] receptor subunit epsilon-1, hNR2A, NR2A, Glutamate receptor ionotropic, NMDA 2A, GRIN2A, GluN2A
-
Pathways
- Synaptic Membrane, Regulation of long-term Neuronal Synaptic Plasticity
Target
-